Literature DB >> 9423801

Small, dense LDL particle concentration correlates with plasminogen activator inhibitor type-1 (PAI-1) activity.

S Väisänen1, M W Baumstark, I Penttilä, C Bouchard, P Halonen, T Rankinen, A Berg, R Rauramaa.   

Abstract

The relation between LDL subfractions and fibrinolytic activity was studied in 150 men aged 53 to 63 years. Apolipoprotein B (apoB) concentration in the most dense LDL-5 (r = 0.39, p <0.001) and LDL-6 (r = 0.43, p <0.001) subfractions associated with plasminogen activator inhibitor type-1 (PAI-1) activity. Subjects in the highest LDL-6 apoB tertile had higher PAI-1 (24.7 vs. 13.1 AU/ml, p <0.001) and lower t-PA (0.26 vs. 0.54 IU/ml, p <0.001) activities than men in the lowest tertile. The difference in PAI-1 remained after adjusting for either triglycerides (p = 0.039) or insulin (p = 0.015) with cardiorespiratory fitness as an additional covariate, and history of cardiovascular disease and smoking as factors. In a regression analysis, plasma insulin and LDL-6 apoB, but not plasma triglycerides and body mass index, entered the model, and explained 30.6 and 3.9% of the variance in PAI-1 activity, respectively. The novel finding of the present study was the independent association between small, dense LDL particles and PAI-1 activity in middle-aged men.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9423801

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  5 in total

1.  Apolipoprotein B versus lipoprotein lipids: vital lessons from the AFCAPS/TexCAPS trial.

Authors:  A D Sniderman; J Bergeron; J Frohlich
Journal:  CMAJ       Date:  2001-01-09       Impact factor: 8.262

2.  The Association Between Small Dense Low Density Lipoprotein and Coronary Artery Disease in North Indian Patients.

Authors:  Pravin K Goel; Fauzia Ashfaq; Roopali Khanna; V Ramesh; Chandra Mohan Pandey
Journal:  Indian J Clin Biochem       Date:  2016-07-04

Review 3.  Pathophysiology of dyslipidaemia in the metabolic syndrome.

Authors:  G D Kolovou; K K Anagnostopoulou; D V Cokkinos
Journal:  Postgrad Med J       Date:  2005-06       Impact factor: 2.401

4.  Serum level of plasminogen activator inhibitor type-1 in addicted patients with coronary artery disease.

Authors:  Afsaneh Forood; Reza Malekpour-Afshar; Amin Mahdavi
Journal:  Addict Health       Date:  2014 Summer-Autumn

5.  Plasminogen Activator Inhibitor-1 Level Correlates with Lipoprotein Subfractions in Obese Nondiabetic Subjects.

Authors:  Sándor Somodi; Ildikó Seres; Hajnalka Lőrincz; Mariann Harangi; Péter Fülöp; György Paragh
Journal:  Int J Endocrinol       Date:  2018-05-30       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.